构成协同作用的纳米配方的开发,以增强T细胞白血病的化学敏感性
James M Kelvin1, Madison L Chimenti2, Dan Y Zhang3
1Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30322, USA.
概括
研究人员确定了MRX-2843和温克里斯的协同组合,用于治疗急性淋巴细胞白血病 (ALL). 这种通过纳米粒子输送的组合在临床前模型中显示出更好的疗效,为复发性或耐火性ALL提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 急性淋巴细胞白血病 (ALL) 的存活率对于那些对化疗无反应或复发的患者来说仍然很低.
- 新的治疗策略对于克服ALL的化疗耐药性至关重要.
研究的目的:
- 为了确定与MRX-2843的协同药物组合,用于治疗ALL.
- 开发和评估基于纳米粒子的药物输送系统,以加强ALL治疗.
主要方法:
- 高通量药物查以确定与MRX-2843.4的协同作用组合.
- 开发多剂型脂质纳米颗粒配方,用于同时提供MRX-2843和温克里斯.
- 在所有细胞系和初级患者样本上进行体外检测.
- 在体内对早期胸膜前体T-ALL (ETP-ALL) 的正位体鼠异种移植模型进行评估.
主要成果:
- 根据比例,MRX-2843与温克里斯对B-ALL和T-ALL细胞系进行了协同作用.
- 脂质纳米粒子配方改善了抗白血病活性,并通过细胞内输送药物.
- 在初级T-ALL患者样本中观察到协同作用和添加作用.
- 在临床前ETP-ALL模型中,纳米颗粒配方减少了疾病负担和延长了生存时间.
- 治疗疗效取决于药物剂量和比例,MRX-2843增强了温克里斯的敏感性.
结论:
- 对药物查和纳米颗粒输送的综合系统方法确定了T-ALL.的强有力的治疗策略.
- 通过纳米颗粒输送的联合MRX-2843和温克里斯显示出治疗复发性/耐药性ALL的巨大潜力.
- 这种方法提供了一种新的转化剂,可以增强T-ALL患者的温克里斯反应,并可将其推广到其他癌症.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K


